首页> 美国政府科技报告 >Analysis of Corporate Acquisitions by Medical Device Manufacturers Final rept. (July 1 2000-June 30 2002)
【24h】

Analysis of Corporate Acquisitions by Medical Device Manufacturers Final rept. (July 1 2000-June 30 2002)

机译:医疗器械制造商的公司收购分析最终报告(2000年7月1日 - 2002年6月30日)

获取原文

摘要

To investigate conditions under which corporate acquisitions in the medical device industry have enhanced or eroded shareholder wealth and financial accounting performance. One emphasis is whether building product lines within medical specialties (e.g., cardiology, orthopedics) via acquisition is a value-creating strategy among medical device manufacturers. The medical device industry is defined as firms manufacturing products in Standard Industrial Classification codes 3841, 3842, 3844, and 3845. The unit of analysis is the portfolio combination of acquirer/target pairs. Acquisitions announced during the 16-year period 1984- 1999 are investigated (n=273, averaging one every three weeks). Post-acquisition accounting performance evaluation periods of 2, 3, and 4 years are analyzed, so financial data under study extend through 2003. The analysis follows a systematic framework for estimating and presenting regression models to provide evidence of the consistency and robustness of results patterns across alternative models and specifications.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号